No significant decrease in antibiotic use from 1992 to 2000, in the French community

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 524-528

  Sommet, Agnès ^a   Sermet, Catherine ^b   Boëlle, Pierre Yves ^c   Tafflet, Muriel ^b   Bernède, Claire ^a   Guillemot, Didier ^a  

^a INSTITUT PASTEUR   (France)

^b Ctr Rech Docum/Econ de la Sante   (France)

^c INSERM   (France)

Author keywords

Anti infectives; Pharmacoepidemiology; Public health

Indexed keywords

ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHITIS; CHILD; COMMUNICABLE DISEASE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG UTILIZATION; FEMALE; FRANCE; GASTROENTERITIS; GROUPS BY AGE; HEALTH SURVEY; HUMAN; INFLUENZA; LARYNGITIS; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; PNEUMONIA; POPULATION RESEARCH; RHINOPHARYNGITIS; SINUSITIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TRACHEITIS; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DATA COLLECTION; DRUG UTILIZATION; FEMALE; FRANCE; HUMANS; INFANT; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PHARYNGITIS; PRESCRIPTIONS, DRUG; RESPIRATORY TRACT INFECTIONS; SEASONS;

EID: 4444228680     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh342     Document Type: Article

References (26)

1. Bronzwaer, S. L., Cars, O., Buchholz, U. et al. (2002). A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerging Infectious Diseases 8, 278-82.
2. Nasrin, D., Collignon, P. J., Roberts, L. et al. (2002). Effect of β-lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. British Medical Journal 324, 28-30. 7<<>>⌋py1 2002
3. Melander, E., Ekdahl, K., Jonsson, G. et al. (2000). Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatric Infectious Disease Journal 19, 1172-7.
4. Seppala, H., Klaukka, T., Vuopio-Varkila, J. et al. (1997). The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. New England Journal of Medicine 337,441-6.
5. Garcia-Rey, C., Aguilar, L., Baquero, F. et al. (2002). Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. Journal of Clinical Microbiology 40, 2959-63.
6. Granizo, J. J., Aguilar, L., Casal, J. et al. (2000). Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (11986-1997). Journal of Antimicrobial Chemotherapy 46, 959-64.
7. Goettsch, W., van Pelt, W., Nagelkerke, N. et al. (2000). Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands. Journal of Antimicrobial Chemotherapy 46, 223-8.
8. Olafsson, M., Kristinsson, K. G. & Sigurdsson, J. A. (2000). Urinary tract infections, antibiotic resistance and sales of antimicrobial drugs - an observational study of uncomplicated urinary tract infections in Icelandic women. Scandinavian Journal of Primary Health Care 18, 35-8.
9. Leflon-Guibout, V., Ternat, G., Heym, B. et al. (2002). Exposure to co-amoxiclav as a risk factor for co-amoxiclav-resistant Escherichia coli urinary tract infection. Journal of Antimicrobial Chemotherapy 49, 367-71.
10. Cars, O., Molstad, S. & Melander, A. (2001). Variation in antibiotic use in the European Union. Lancet 357, 1851-3.
11. European Antimicrobial Resistance System. (2002). EARSS Annual Report 2002. [Online.] http://www.earss.rivm.nl (15 April 2004, date last accessed).
12. Soares, S., Kristinsson, K. G., Musser, J. M. et al. (1993). Evidence for the introduction of a multiresistant clone of serotype 6B Streptococcus pneumoniae from Spain to Iceland in the late 1980s. Journal of Infectious Diseases 168, 158-63.
13. Elseviers, M., Ferech, M., Vanderstichele, R. et al. (2003). Consumption of ambulatory care in Europe. In Abstracts of the Thirteenth European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 2003. Abstract O200, p. 52. European Society of Microbiology and Infectious Diseases, Basel, Switzerland.
14. European Surveillance of Antimicrobial Consumption. (2001). Recommendations of the European Conference on Antibiotic Use in Europe. [Online.] http://www.uia.ac.be/esac/Recommendations.htm (15 April 2004, date last accessed).
15. Guillemot, D., Maison, P., Carbon, C. et al. (1998). Trends in antimicrobial drug use in the community - France, 1981-1992. Journal of Infectious Diseases 177, 492-7.
16. Dumesnil, S., Grandfils, N. & Le Fur, P. (1998). Methode et déroulement de I'Enquête sur la Santé et la Protection Sociale, p. 1775. CREDES, Paris, France.
17. WHO Collaborating Centre for Drug Statistics Methodology (2002). Anatomical Therapeutic Chemical Classification System for Drugs. Oslo, Norway.
18. National Center for Health Statistics (NCHS)-WHO Collaborating Center for the Family of International Classifications for North America (1998). International Classification of Diseases, Ninth Revision, Clinical Modification. Public Health Service, US Department of Health and Human Services, Washington, DC, USA.
19. Flahault, A., Boussard, E., Vibert, J. F. et al. (1997). Sentiweb remains an efficient tool for nationwide surveillance of disease. British Medical Journal 314, 1418.
20. Institut National des Statistiques et des Etudes Economiques. (1999). National Population Census. [Online.] http://www.recensement.insee.fr/(115 April 2004, date last accessed).
21. McCaig, L. F., Besser, R. E. & Hughes, J. M. (2003). Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerging Infectious Diseases 9, 432-7.
22. Observatoire National des Prescriptions et Consommations des Médicaments. (1998). Etude de la prescription et de la consommation des antibiotiques en ambulatoire. Agence du Mé dicament, Direction des Etudes et de I'Information Pharmaco-Economiques, Paris, France.
23. Groupe de travail sur la Maîtrise de la résistance aux antibiotiques. (1999). Propositions au Secrétaire d'Etat à la Santé et à I'Action Sociale pour un plan national d'actions pour la maîtrise de la résistance aux antibiotiques. Réseau National de Santé Publique, Saint-Maurice, France.
24. Meyer, M., Guillemot, D., Maugendre, P. et al. (2003). Consumption of antibiotics in France: first results of the ESAC retrospective data collection. In Abstracts of the Thirteenth European Congress of Clinical Microbiology and Infectious Diseases, Glasgow, UK, 2003. Abstract P1473, p. 387. European Society of Microbiology and Infectious Diseases, Basel, Switzerland.
25. Nyquist, A. C., Gonzales, R., Steiner, J. F. et al. (1998). Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. Journal of the American Medical Association 279, 875-7.
26. Linder, J. A. & Stafford, R. S. (2001). Antibiotic treatment of ART with sore throat by community primary care physicians: a national survey, 1989-1999. Journal of the American Medical Association 286, 1181-6.